Dicomit gets clearance for 3-D module

Article

Dicomit DICOM Information Technologies has released 3-D ROI (region of interest), a 3-D upgrade that allows sonographers and radiologists to construct 3-D volumes on any ultrasound monitor or a networked remote viewing station, according to the

Dicomit DICOM Information Technologies has released 3-D ROI (region of interest), a 3-D upgrade that allows sonographers and radiologists to construct 3-D volumes on any ultrasound monitor or a networked remote viewing station, according to the Richmond Hill, Ontario-based company. Available as an option on new Dicomit products or as an upgrade to Dicomit’s installed base, 3-D ROI can also be embedded as a software module in an ultrasound machine or a review station.

Users can obtain an immediate 3-D volume and rotate images 360º without image degradation, according to the firm. Oblique slices can be viewed quickly, and volume visualized with additional 2-D images in three planes, according to Dicomit. 3-D ROI will be available in the U.S. and internationally through Dicomit’s OEM customers.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.